← Back to headlines
Eli Lilly Announces Positive Phase 3 Results for Obesity Drug Retatrutide
Eli Lilly (LLY) has reported positive Phase 3 clinical trial results for its investigational obesity treatment, Retatrutide, marking a significant development in the pharmaceutical company's pipeline.
23 May, 12:01 — 23 May, 12:01
Sources
Showing 1 of 1 sources
Related Stories
Dolly Parton Misses Dollywood Event Due to Health Issues, Fans Concerned
1h ago
Supermarkets including Spar, Dirk and Plus warn of undercooked chicken thigh skewers
10h ago
Bengaluru Engineer Kills Wife, Dies by Suicide
10h ago
Motorcyclist in his 30s killed in single-vehicle collision in Co Galway
14h ago